Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Hiraoka A, Ishimaru Y, Kawasaki H, Aibiki T, Okudaira T, Toshimori A, Kawamura T, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Oncology. 2015;89(3):167-74. doi: 10.1159/000381808. Epub 2015 May 12. Oncology. 2015. PMID: 25999038
Huge pancreatic acinar cell carcinoma with high levels of AFP and fucosylated AFP (AFP-L3).
Hiraoka A, Nakahara H, Kawasaki H, Shimizu Y, Hidaka S, Imai Y, Utsunomiya H, Tatsukawa H, Tazuya N, Yamago H, Yorimitsu N, Tanihira T, Hasebe A, Miyamoto Y, Ninomiya T, Abe M, Hiasa Y, Matsuura B, Onji M, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Intern Med. 2012;51(11):1341-9. doi: 10.2169/internalmedicine.51.6536. Epub 2012 Jun 1. Intern Med. 2012. PMID: 22687839 Free article. Review.
Prognosis and therapy for ruptured hepatocellular carcinoma: problems with staging and treatment strategy.
Hiraoka A, Kawamura T, Aibiki T, Okudaira T, Toshimori A, Yamago H, Nakahara H, Suga Y, Azemoto N, Miyata H, Miyamoto Y, Ninomiya T, Murakami T, Ishimaru Y, Kawasaki H, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Eur J Radiol. 2015 Mar;84(3):366-371. doi: 10.1016/j.ejrad.2014.11.038. Epub 2014 Dec 15. Eur J Radiol. 2015. PMID: 25554005
Usefulness of albumin-bilirubin grade for evaluation of prognosis of 2584 Japanese patients with hepatocellular carcinoma.
Hiraoka A, Kumada T, Michitaka K, Toyoda H, Tada T, Ueki H, Kaneto M, Aibiki T, Okudaira T, Kawakami T, Kawamura T, Yamago H, Suga Y, Miyamoto Y, Tomida H, Azemoto N, Mori K, Miyata H, Ninomiya T, Kawasaki H. Hiraoka A, et al. Among authors: yamago h. J Gastroenterol Hepatol. 2016 May;31(5):1031-6. doi: 10.1111/jgh.13250. J Gastroenterol Hepatol. 2016. PMID: 26647219
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Mori I, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19. J Gastroenterol Hepatol. 2018. PMID: 29193248
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H, Hiraoka A, Ishimaru Y, Murakami T, Kitahata S, Ueki H, Aibiki T, Okudaira T, Miyamoto Y, Yamago H, Iwasaki R, Tomida H, Mori K, Kishida M, Tsubouchi E, Miyata H, Ninomiya T, Kawasaki H, Hirooka M, Matsuura B, Abe M, Hiasa Y, Michitaka K, Kudo M. Izumoto H, et al. Among authors: yamago h. Oncology. 2017;93 Suppl 1:120-126. doi: 10.1159/000481242. Epub 2017 Dec 20. Oncology. 2017. PMID: 29258105
Combination of Resection and Ablative Treatment for Hepatocellular Carcinoma: Usefulness of Complementary Radiofrequency Ablation.
Hiraoka A, Hirooka M, Ochi H, Koizumi Y, Izumoto H, Ueki H, Tsuruta M, Ono A, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Kishida M, Tsubouchi E, Abe M, Matsuura B, Ninomiya T, Joko K, Kawasaki H, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: yamago h. Oncology. 2019;96(5):242-251. doi: 10.1159/000496225. Epub 2019 Mar 20. Oncology. 2019. PMID: 30893698
Ultrasonography surveillance improves prognosis of patients with hepatocellular carcinoma.
Yamago H, Hiraoka A, Murakami T, Izumoto H, Ueki H, Ochi M, Aibiki T, Okudaira T, Iwasaki R, Suga Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Hiasa Y, Michitaka K. Yamago H, et al. Mol Clin Oncol. 2019 Sep;11(3):325-330. doi: 10.3892/mco.2019.1888. Epub 2019 Jun 25. Mol Clin Oncol. 2019. PMID: 31384461 Free PMC article.
Exacerbation of psoriasis vulgaris by sorafenib treatment for hepatocellular carcinoma.
Adachi T, Hiraoka A, Okazaki H, Nagamatsu K, Izumoto H, Yoshino T, Tsuruta M, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Suga Y, Mori K, Miyata H, Tsubouchi E, Ninomiya T, Michitaka K. Adachi T, et al. Among authors: yamago h. Clin J Gastroenterol. 2020 Oct;13(5):891-895. doi: 10.1007/s12328-020-01134-3. Epub 2020 May 28. Clin J Gastroenterol. 2020. PMID: 32468502
30 results